Why is this medication prescribed?

Palivizumab is a medication used to prevent serious respiratory tract infections caused by the respiratory syncytial virus (RSV) in certain high-risk populations, particularly in infants and young children. RSV is a common virus that can cause respiratory infections, especially in young children and premature infants. In some cases, RSV infections can lead to more severe respiratory problems such as bronchiolitis and pneumonia.

Palivizumab is typically prescribed for the following groups of infants and children who are at high risk of developing severe RSV infections:

• Premature Infants: Infants born prematurely, especially those born before 29 weeks of gestation.
• Infants with Chronic Lung Disease: Infants with chronic lung disease (bronchopulmonary dysplasia) who require medical treatment.
• Infants with Congenital Heart Disease: Infants with certain types of congenital heart disease, particularly those who have required treatment in the past six months.
• Infants with Other High-Risk Conditions: Infants and children with certain high-risk conditions or medical histories that make them more susceptible to severe RSV infections.

How should this medicine be used?

Palivizumab works by providing temporary protection against RSV, reducing the risk of severe infection and hospitalization. It is usually administered as an injection. Here are some general guidelines for the use of Palivizumab:

• Dosage: The dosage of Palivizumab is based on the child’s weight, and it is typically administered once a month during the RSV season, which often occurs in the fall and winter months.
• Administration: Palivizumab is given as an intramuscular injection (injection into the muscle), usually in the thigh. Healthcare professionals will administer the injection.
• Timing: The timing of Palivizumab administration is important. It is typically given throughout the RSV season to provide continuous protection during the period of increased risk.
• Duration: The duration of Palivizumab treatment varies depending on the child’s risk factors and the recommendations of the healthcare provider.

It’s crucial to follow the healthcare provider’s instructions and the recommended schedule for Palivizumab administration. Additionally, parents and caregivers should report any side effects or concerns to the healthcare provider promptly.

Please note that individual cases may vary, and the information provided here is a general overview. It’s essential to consult with a healthcare professional for personalized advice and guidance based on the specific medical condition of the child.

Other uses for this medicine

Palivizumab is primarily used for the prevention of serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in certain high-risk infants and children. As of last update, this remains its primary indication. However, it’s essential to consult with a healthcare professional or check more recent medical sources for any updates or changes in its approved uses.

What special precautions should I follow?

As for special precautions when using Palivizumab, consider the following:

• Allergies: Inform the healthcare provider about any allergies, especially to Palivizumab or any other ingredients in the formulation.
• Medical History: Provide a comprehensive medical history, including any history of immune system disorders or other significant health conditions.
• Current Medications: Disclose all medications, including prescription, over-the-counter, and herbal supplements, that the child is currently taking. This information helps to prevent potential interactions.
• Pregnancy and Breastfeeding: If the child’s mother is pregnant or breastfeeding, it’s essential to discuss the risks and benefits of Palivizumab with the healthcare provider.
• Vaccinations: Palivizumab is not a substitute for routine childhood vaccinations. Ensure that the child continues to receive all recommended vaccines as per the vaccination schedule.
• Monitoring: Regularly monitor the child for any signs of infection or adverse reactions. Report any unusual symptoms or side effects to the healthcare provider promptly.
• Follow the Schedule: Adhere to the prescribed schedule for Palivizumab administration. Missing doses or deviating from the recommended timing may impact the effectiveness of the medication.
• Storage: Follow proper storage instructions for Palivizumab. Pay attention to temperature requirements and ensure that the medication is stored correctly.

Remember that the information provided here is based on knowledge, and there may have been updates or changes in recommendations since then. Always consult with a healthcare professional for the most current and personalized advice based on the specific medical condition and needs of the child.

What special dietary instructions should I follow?

As of last update, there are no specific dietary restrictions associated with Palivizumab. However, it’s always a good idea to discuss any concerns or questions about the child’s diet with the healthcare provider.

What should I do if I forget a dose?

If you forget a scheduled dose of Palivizumab, it’s crucial to contact the healthcare provider or clinic as soon as possible. They will provide guidance on whether the missed dose can be administered at a later time or if adjustments to the schedule are needed.

It’s generally not recommended to double up on doses to make up for a missed one without consulting the healthcare provider first.

What side effects can this medication cause?

Palivizumab is generally well-tolerated, but like any medication, it may cause side effects in some individuals. It’s important to note that not everyone will experience these side effects, and some people may experience side effects that are not listed. If you have concerns about potential side effects, it’s recommended to discuss them with the healthcare provider. As of last update, the common side effects of Palivizumab include:

• Injection Site Reactions: Redness, swelling, or pain at the injection site may occur. These reactions are usually mild and temporary.
• Fever: A mild fever may occur after receiving Palivizumab.
• Rash: Some children may develop a rash as a side effect.
• Cough or Runny Nose: Respiratory symptoms such as cough or runny nose may occur.
• Ear Infections: There have been reports of increased ear infections in children receiving Palivizumab.
• Vomiting: Some children may experience vomiting.
• Diarrhea: Diarrhea has been reported as a side effect in some cases.
• Serious allergic reactions: Serious allergic reactions to Palivizumab are rare but may occur. Seek medical attention immediately if you notice signs of a severe allergic reaction, such as difficulty breathing, swelling of the face or throat, or severe rash.

It’s important to report any unusual or severe side effects to the healthcare provider promptly. The benefits of Palivizumab in preventing severe respiratory syncytial virus (RSV) infections generally outweigh the risks for those at high risk, but individual responses can vary.

Always consult with a healthcare professional for the most up-to-date information and guidance tailored to the specific health needs of the child.

What should I know about storage and disposal of this medication?

Storage and Disposal of Palivizumab Injection:

Storage:

• Follow the storage instructions provided by the healthcare provider or pharmacist.
• Palivizumab is usually stored in a refrigerator, and it is important to keep it at the recommended temperature.
• Do not freeze the medication.
• Keep Palivizumab out of reach of children.

Disposal:

• Dispose of used needles and syringes in a puncture-resistant container.
• Follow local regulations for the proper disposal of medical waste.
• If you have any questions about how to dispose of Palivizumab or its components, consult with the healthcare provider or pharmacist.

In case of emergency/overdose

In case of an emergency or suspected overdose, contact your local emergency services or poison control center immediately. The symptoms of an overdose are not well-documented, as Palivizumab is typically administered by healthcare professionals. However, seeking immediate medical attention is crucial if you suspect an overdose.

What other information should I know?

• Follow-Up Appointments: Keep all scheduled follow-up appointments with the healthcare provider. These appointments are important for monitoring the child’s health and ensuring that the medication is effective.
• Routine Vaccinations: Continue to follow the routine childhood vaccination schedule as recommended by the healthcare provider. Palivizumab is not a substitute for routine vaccines.
• Communicate with Healthcare Provider: Report any new or worsening symptoms to the healthcare provider promptly. Open communication is essential for the child’s overall care.
• Patient Information: Be aware of and understand the patient information leaflet provided with Palivizumab. It contains important details about the medication, including potential side effects and other relevant information.
• Medical ID: If advised by the healthcare provider, ensure that the child wears a medical identification bracelet or carries a medical identification card indicating the use of Palivizumab in case of emergency.

Always consult with the healthcare provider or pharmacist for the most current and accurate information regarding the storage, disposal, and emergency procedures related to Palivizumab. The information provided here is based on general guidelines, and individual circumstances may vary.